Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 18;11(11):1720.
doi: 10.3390/biom11111720.

Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology

Nishant V Sewgobind  1 , Sanne Albers  1 , Roland J Pieters  1
Affiliations
Review

Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology

Nishant V Sewgobind et al. Biomolecules. .

Abstract

Galectin-7 is a soluble unglycosylated lectin that is able to bind specifically to β-galactosides. It has been described to be involved in apoptosis, proliferation and differentiation, but also in cell adhesion and migration. Several disorders and diseases are discussed by covering the aforementioned biological processes. Structural features of galectin-7 are discussed as well as targeting the protein intracellularly or extracellularly. The exact molecular mechanisms that lie behind many biological processes involving galectin-7 are not known. It is therefore useful to come up with chemical probes or tools in order to obtain knowledge of the physiological processes. The objective of this review is to summarize the roles and functions of galectin-7 in the human body, providing reasons why it is necessary to design inhibitors for galectin-7, to give the reader structural insights and describe its current inhibitors.

Keywords: apoptosis; epithelial tissues; galectin-7; inhibitors; targeting.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
(a) Dimeric structure of galectin-7 (pdb 1BKZ); (b) N-Ac-LacNAc binding to galectin-7 (pdb 5GAL).
Figure 2
Figure 2
Structures of 1 and 2: these two molecules differ by the presence of the O-benzylphosphate group in 2, compared with an O-methylphosphate group in 1.
Figure 3
Figure 3
Structures of 3 (Galβ1-3GlcNAc, LN1) and 4 (Galβ1-4GlcNAc, LN2).
Figure 4
Figure 4
Structures of 5, 6 and 7 (D1, D2 and D3, respectively).
Figure 4
Figure 4
Structures of 5, 6 and 7 (D1, D2 and D3, respectively).
Figure 5
Figure 5
Structure of 8 (TD139).
Figure 6
Figure 6
Structures of the scaffold 9 and the inhibitors 10 (Kd = 0.17 mM), 11 (Kd = 0.18 mM) and 12 (Kd = 0.14 mM).
Figure 7
Figure 7
Thioureido N-acetyllactosamine derivative 16.
Figure 8
Figure 8
Ditriazolylthio-digalactosides developed by Delaine et al.
Figure 9
Figure 9
Structure of a novel non-carbohydrate galectin-7 inhibitor 27 (TpSPPH2).
See this image and copyright information in PMC

References

    1. Varki A., Cummings R.D., Esko J.D., Stanley P., Hart G.W., Aebi M., Darvill A.G., Kinoshita T., Packer N.H., Prestegard J.H., et al. Essentials of Glycobiology. 3rd ed. Cold Spring Harbor Laboratory Press; New York, NY, USA: 2017. - PubMed
    1. Bertuzzi S., Quintana J.I., Ardá A., Gimeno A., Jiménez-Barbero J. Targeting Galectins With Glycomimetics. Front. Chem. 2020;8:1–17. doi: 10.3389/fchem.2020.00593. - DOI - PMC - PubMed
    1. Si Y., Yao Y., Jaramillo Ayala G., Li X., Han Q., Zhang W., Xu X., Tai G., Mayo K.H., Zhou Y., et al. Human galectin-16 has a pseudo ligand binding site and plays a role in regulating c-Rel-mediated lymphocyte activity. Biochim. Biophys. Acta Gen. Subj. 2021;1865:129755. doi: 10.1016/j.bbagen.2020.129755. - DOI - PubMed
    1. Madsen P., Rasmussen H.H., Flint T., Gromov P., Kruse T.A., Honore B., Vorum H., Celis J.E. Cloning, expression, and chromosome mapping of human galectin-7. J. Biol. Chem. 1995;270:5823–5829. doi: 10.1074/jbc.270.11.5823. - DOI - PubMed
    1. Magnaldo T., Bernerd F., Darmon M. Galectin-7, a Human 14 kDa S-lectin, Specifically Expressed in keratinocytes and Sensitive to Retinoic acid. Dev. Biol. 1995;168:259–271. doi: 10.1006/dbio.1995.1078. - DOI - PubMed

LinkOut - more resources